iXensor’s #Bigbangmoment: partnering with us to make health checks more accessible


The collaboration between the health tech startup iXensor and our CURAFA™ team initiated through our Accelerator, turned out to be a perfect match. Through this partnership, the startup conducted a successful pilot test of their portable healthcare devices within CURAFA™ facilities in Kenya.

Publish Date

22 AUG 2019

iXensor took part in our 2019 Accelerator program at our Innovation Center in our headquarters in Darmstadt, during which the health tech startup was connected with the our team. This collaboration led to the successful pilot study of one of iXensor’s portable devices. The study involved the PixoTest POCT System, which enables the delivery of instant clinical tests for people with diabetes (HbA1c) and cardiovascular diseases (lipid panel) within a single instrument. This helps to support the management of people with these common diseases by enabling on-the-spot advice for effective behavioral change. The pilot has now finished, with users and pharmacies giving a very good response to the operation of the device and tests.

Thanks to this collaboration, the health tech startup could find a partner and contribute to the objective of our CURAFA™ points of care initiative, that aims to improve access to primary healthcare services for underserved communities in emerging economies.

Fascinating topic? Read the full story here

Enjoyed the read?

To keep up to date with all new happenenings at our Innovation Center, click here to subscribe to our e-mail service.


You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Internet Explorer is not supported

You are using an outdated browser. If you would like to use our website, please use Chrome, Firefox, Safari or other browser

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement